Brief: scPharmaceuticals Q2 Revenue USD 8.054 Million Vs. IBES Estimate USD 7.97 Million
Aug 14 (Reuters) - scPharmaceuticals Q2 net income USD -17.09 million vs. IBES estimate USD -16.1 million. * Q2 basic EPS USD -0.44 * Q2 income from operations USD -14.431 million vs. IBES estimate USD -15.1 million * Q2 operating expenses USD 22.485 million